Podcast 23 Aug 2024New German biotech spins out to develop radiotherapeutics While it is currently owned by the Eckert & Ziegler Group, Pentixapharm will soon be spun off as a separate company. Listen to our conversation with Andreas Eckert, founder of the company August 23, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
In Depth 28 Jun 2024 Going nuclear: radiopharmaceuticals funding sees surge in 2024 Emerging as a new class of drugs, radiopharmaceuticals are all the rage in cancer treatment research as biotechs nab major funding deals. June 28, 2024 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 26 Jun 2024 Biotech megadeals: Exploring the surge in $100M+ deals Biotech and healtcare contributed to more than one out of three megadeals in 2024, find out the reasons behind it. June 26, 2024 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 24 Jun 2024 Troublesome acquisitions: when biotech M&A goes wrong Dive deeper into the world of M&A, as we take a look at some of the most prominent failed acquisitions of the last decade. June 24, 2024 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 17 Jun 2024 Moving with the times: biopharma royalty deals on the rise A spate of royalty deals are changing the way certain biotechs press ahead. This trend seems to be an alternative to traditional biopharma fundraising. June 17, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Podcast 19 Apr 2024The biotech investment landscape in 2024 Dive into 2024’s biotech investment strategies with RTW Investments on our podcast. Discover trends shaping the landscape ahead.” April 19, 2024 Share WhatsApp Twitter Linkedin Email
Best in Biotech 9 Apr 2024 Eight biotech companies you should know about in Austria Here are eight Austrian biotech companies that have received funding in recent years to propel their pioneering innovations forward. April 9, 2024 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 8 Apr 2024 A wave of biotech layoffs: will the trend continue throughout 2024? Thousands of jobs have been at risk over the past year due to mass layoffs by biotech companies across the globe. April 8, 2024 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 21 Mar 2024 Biotech in France: What’s holding back progress and how to move forward? Explore the latest insights from France Biotech’s ‘Panorama France HealthTech’ report, uncovering key insights of the French biotech sector. March 21, 2024 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 18 Mar 2024 Will the US biotech funding surge trigger a renaissance in the global biotech industry? After a couple of challenging years in biotech investment, the US leads the march for recovery. Delve into the specifics driving this uptick. March 18, 2024 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 11 Mar 2024 Biotech bankruptcies: what to expect in 2024 following a record year? 2023 broke the record for the highest number of biotech bankruptcies in a decade. Can biotechs mitigate the risk in 2024? March 11, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 7 Mar 2024 Can AbbVie’s legacy live beyond its once best-selling drug Humira? The sales of AbbVie’s Humira, once a best-seller, have dropped. Now, with a new CEO announced, things are about to change for the company. March 7, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email